(Q37104298)

18 August 2017

1 reference

title

Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach (English)

1 reference

18 August 2017

body dysmorphic disorder

1 reference

2

Eric Hollander

1 reference

18 August 2017

Katharine A Phillips

1

1 reference

18 August 2017

5 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

1

1 reference

18 August 2017

13-27

1 reference

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

The relationship between antidepressant prescription rates and rate of early adolescent suicide

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Suicidality in body dysmorphic disorder: a prospective study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

An open-label study of escitalopram in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Psychosocial functioning and quality of life in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Pharmacologic treatment of depression in patients with heart disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Insight in obsessive compulsive disorder and body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Axis I comorbidity in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Prevalence of body dysmorphic disorder in a community sample of women

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Delusionality and response to open-label fluvoxamine in body dysmorphic disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Adult brain neurogenesis and psychiatry: a novel theory of depression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Efficacy and safety of fluvoxamine in body dysmorphic disorder.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Treatment of body-dysmorphic disorder with serotonin reuptake blockers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Body dysmorphic disorder: the distress of imagined ugliness

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Pharmacologic treatment of body dysmorphic disorder.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

An open-label study of citalopram in body dysmorphic disorder.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Predictive validity of the overvalued ideas scale: outcome in obsessive-compulsive and body dysmorphic disorders

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

A meta-analysis of psychological and pharmacological treatments for Body Dysmorphic Disorder.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Suicidal ideation and suicide attempts in body dysmorphic disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Psychosis in body dysmorphic disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Quality of life for patients with body dysmorphic disorder.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

The Brown Assessment of Beliefs Scale: reliability and validity.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Gender differences in body dysmorphic disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Epidemiology of somatoform disorders: a community survey in Florence.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Fluvoxamine treatment of body dysmorphic disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705931

Response of major depression with psychosis and body dysmorphic disorder to ECT

20 October 2018

1 reference

12 December 2020

Sertraline for body dysmorphic disorder

1 reference

12 December 2020

Prevalence and clinical features of body dysmorphic disorder in atypical major depression

1 reference

12 December 2020

Body Dysmorphic Disorder

1 reference

12 December 2020

Body dysmorphic disorder

1 reference

12 December 2020

A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale

1 reference

12 December 2020

SSRI for body dysmorphic disorder

1 reference

12 December 2020

Comparison of clinical characteristics in obsessive-compulsive disorder and body dysmorphic disorder

1 reference

12 December 2020

Muscle dysmorphia. An underrecognized form of body dysmorphic disorder

1 reference

12 December 2020

Thirty-three cases of body dysmorphic disorder in children and adolescents

1 reference

12 December 2020

The prevalence of body dysmorphic disorder: a population-based survey

1 reference

12 December 2020

Suicide attempts among patients starting depression treatment with medications or psychotherapy

1 reference

12 December 2020

Prevalence and Clinical Features of Body Dysmorphic Disorder in Adolescent and Adult Psychiatric Inpatients

1 reference

12 December 2020

Monosymptomatic hypochondriacal psychosis: a diagnostic checklist based on 50 cases of the disorder

1 reference

12 December 2020

Clomipramine treatment of delusional disorder-somatic type

1 reference

12 December 2020

Body dysmorphic disorder: the relationship to obsessive-compulsive disorder

1 reference

12 December 2020

Body dysmorphic disorder: 30 cases of imagined ugliness

1 reference

12 December 2020

10.1016/J.BODYIM.2007.12.003

Identifiers

DOI

1 reference

18 August 2017

1 reference

PMC publication ID

2705931

18 August 2017

PubMed publication ID

18325859

1 reference

PMC publication ID

2705931